Prescribing and monitoring non‐biological DMARDs

Abstract

The British Society for Rheumatology and British Health Professionals in Rheumatology (BSR/BHPR) recently updated their guidance on prescribing and monitoring non‐biological disease‐modifying antirheumatic drugs (DMARDs) for patients with rheumatic disease. This article provides an overview of the main recommendations of the new guideline.